Nivolumab (Opdivo) Concentrate for Infusion
Nivolumab is a human monoclonal antibody PD-1 inhibitor for melanoma and lung cancer immunotherapy. Classified in HTS 3002.15.00.11 as it directly regulates immunological processes via checkpoint inhibition, in measured retail vials.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If part of complex cancer therapy mixture
Multicomponent medicaments classify under 3004 if not unmixed immunological.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Provide PD-1 binding assay data; ensure oncology-specific FDA pathways
• Use validated cold chain with data loggers for immunotherapy stability
Related Products under HTS 3002.15.00.11
Rituximab Monoclonal Antibody Injection
Rituximab is a genetically engineered chimeric monoclonal antibody targeting CD20 on B-cells, used for treating non-Hodgkin lymphoma and rheumatoid arthritis. It falls under HTS 3002.15.00.11 as an immunological product containing monoclonal antibodies, put up in measured doses for retail sale in pre-filled syringes or vials.
Trastuzumab (Herceptin) Infusion Vial
Trastuzumab is a humanized monoclonal antibody against HER2 protein, used in HER2-positive breast cancer therapy. Classified under HTS 3002.15.00.11 for its immunological role in targeted cancer treatment, supplied in measured dose vials for retail pharmacy sale.
Infliximab (Remicade) Lyophilized Powder
Infliximab is a chimeric monoclonal antibody against TNF-alpha for psoriasis and ulcerative colitis. HTS 3002.15.00.11 applies to this biotech-derived immunological product in measured retail doses for reconstitution.
Pembrolizumab (Keytruda) Injection
Pembrolizumab targets PD-1 for advanced cancer immunotherapy like Hodgkin lymphoma. HTS 3002.15.00.11 covers this monoclonal antibody immunological product in pre-filled syringes for retail therapeutic use.
Cetuximab (Erbitux) Infusion Kit
Cetuximab is a chimeric monoclonal antibody against EGFR for colorectal cancer. Under HTS 3002.15.00.11 for retail-measured doses regulating tumor immunology.
Denosumab (Prolia) Prefilled Syringe
Denosumab is a human monoclonal antibody inhibiting RANKL for osteoporosis. HTS 3002.15.00.11 applies to this immunological product in retail syringes.